A medtech product’s market niche and patentability are critical factors in winning seed funding, according to a panel of startup experts at an Innovators’ Forum at Boston Children’s Hospital this week.
Innovation
Realizing the value of med-tech innovations
World’s richest doc shares his vision of healthcare’s future | MassDevice.com On Call
MASSDEVICE ON CALL — Dr. Patrick Soon-Shiong has made a name for himself as the world’s richest doctor and a controversial figure in medicine, but he’s also a fearless visionary.
He has gotten himself into hot water when reality didn’t match up to his promises, but he’s also sparked a lot of interest from healthcare providers around the country who are interested in his prescription for how to fix healthcare.
OPENPediatrics: A blueprint for big innovation
By Lisa Fratt
My father had a favorite bit of advice as we embarked on our adult lives: "Go big or go home." Going big is exactly what OPENPediatrics is doing, empowering physicians and nurses to care for children across the globe.
World’s 1st 3D-printed vertebra goes to a 12-year-old boy | MassDevice.com On Call
MASSDEVICE ON CALL — In a breakthrough surgery a team of physicians at Peking University implanted a 3D-printed vertebra for the 1st time in a 12-year-old boy with a malignant tumor on his spinal cord.
Are device makers falling behind in the digital revolution?
The healthcare space is getting a major influx of digital innovation, but much of it’s coming from outside the traditional parameters of the industry.
Second Sight Medical lands French funding for ‘bionic eye’
Second Sight Medical announced this week that it landed a financial contract with the French Ministry of Health to provide funding for the 1st wave of patients in the country to receive treatment with the Argus II vision system.
T2 Biosystems IPO raises $57M for MRI-based diagnostics
Massachusetts-based T2 Biosystems (NSDQ:TTOO) fell below target with its initial public offering today, raising $57 million in support of its MRI-based diagnostic systems.
T2 Biosystems boosts IPO cap to $78.2M
Massachusetts-based T2 Biosystems raised its hopes for its upcoming initial public offering, raising its maximum aggregate take to $78.2 million if shares sell at $17 apiece.
Can Big Data help detect silent hypertension? | MassDevice.com On Call
MASSDEVICE ON CALL — A computer algorithm may be able to help physicians monitor patients for signs of hypertension, a disease known as "the silent killer."
Researchers at Northwestern Medicine developed a trio of algorithms to review patients’ electronic health records and alert healthcare providers that a patient may have or may be developing hypertension.